Summary
CMS Administrator Dr. Mehmet Oz holds a White House press briefing discussing drug pricing reforms, including most favored nation pricing and a new website for price transparency. He also announces a $50/month cap on GLP-1 drugs for Medicare beneficiaries and highlights anti-fraud efforts in Medicaid and Medicare.
- The administration negotiated most favored nation drug pricing with 17 major pharmaceutical companies, expected to save $600 billion over 10 years.
- Trump rx.gov website now lists over 750 drugs to help consumers compare prices.
- Starting July 1, Medicare beneficiaries can obtain GLP-1 weight loss drugs for $50 per month.
- Oz detailed anti-fraud initiatives, including suspending payments to hundreds of hospices in California.
- Work requirement rules for Medicaid were discussed as part of the Working Families Tax Cut legislation.
- The briefing covered efforts to prevent illegal immigrants from receiving Medicaid benefits.
- Oz praised the president's health and mental acuity during a routine checkup.
- No actionable trading ideas were presented; the briefing focused on government policy and program updates.